A detailed history of Capital City Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital City Trust CO holds 816 shares of LLY stock, worth $721,727. This represents 0.2% of its overall portfolio holdings.

Number of Shares
816
Previous 816 -0.0%
Holding current value
$721,727
Previous $634,000 16.4%
% of portfolio
0.2%
Previous 0.18%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$592.2 - $792.28 $42,638 - $57,044
-72 Reduced 8.11%
816 $634,000
Q4 2023

Jan 19, 2024

BUY
$525.19 - $619.13 $11,028 - $13,001
21 Added 2.42%
888 $517,000
Q3 2023

Oct 12, 2023

SELL
$434.7 - $599.3 $34,776 - $47,944
-80 Reduced 8.45%
867 $465,000
Q1 2023

Apr 19, 2023

BUY
$310.63 - $364.82 $2,485 - $2,918
8 Added 0.85%
947 $325,000
Q4 2022

Jan 27, 2023

BUY
$321.55 - $374.67 $27,331 - $31,846
85 Added 9.95%
939 $0
Q2 2022

Jul 15, 2022

BUY
$278.73 - $327.27 $238,035 - $279,488
854 New
854 $277,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $840B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Capital City Trust CO Portfolio

Follow Capital City Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital City Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Capital City Trust CO with notifications on news.